UC Davis Home | Students | Faculty | Alumni & Friends | Giving
Picture of Robert H Weiss


Robert H Weiss


Nephrology (Internal Med)
Chief of Nephrology, Sacramento VA Medical Center

GBSF rm 6312
(530) 752-4010


1991 University of California, San Francisco Fellowship, Nephrology
1984 MD University of California, Irvine Medicine
1980 MS University of California, Los Angeles Medical Physics
1978 MS University of California, Los Angeles Physical Chemistry
1976 BA University of California, Santa Cruz Chemistry

Research Interests:

cyclins and cyclin inhibitors, cancer growth control, metabolomics and proteomics, polycystic kidney disease

Department and Center Affiliations:

UC Davis Cancer Center

CBS Graduate Group Affiliations:

Molecular, Cellular, and Integrative Physiology  

Specialties / Focus:


Graduate Groups not Housed in CBS:

Immunology Comparative Pathology  
Comparative Pathology  


Last updated 5/21/2010
Weiss RH, Joo A and CJ Randour. 2000. p21Waf1/Cip1 is an assembly factor required for PDGF-induced vascular smooth muscle cell proliferation. Journal of Biological Chemistry. 275:10285-10290

Davis BB, Thompson DA, Howard LL, Morisseau C, Hammock BD and RH Weiss. 2002. Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation. Proceedings of the National Academy of Sciences (USA). 99(4):2222-2227

Lin, P.Y., Fosmire, S.P., Baksh, S., Modiano, J.F., Weiss, R.H. Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance, Molecular Cancer, 6:16, 2007

Park, S.H., Park, J.Y., Weiss, R.H. Antisense attenuation of p21 sensitizes kidney cancer to apoptosis in response to conventional DNA-damaging chemotherapy associated with enhancement of phospho-p53, Journal of Urology 180(1):352-60, 2008

Park, S.H., Wang, X., Liu, R., Lam, K.S., Weiss, R.H. High throughput screening of a small molecule one-bead-one-compound combinatorial library to identify attenuators of p21 as chemotherapy sensitizers, Cancer Biology & Therapy, 7(12), 2015-22, 2008

Kim, K.M., Aronov, P.A., Zakharkin, S.O., Anderson, D., Perroud, B., Weiss, R.H., Urine metabolomic analysis for kidney cancer detection and biomarker discovery, Molecular and Cellular Proteomics, 8(3):558-70, 2009

Perroud, B., Ishimaru, T., Borowsky, A.D., Weiss, R.H. Grade-dependent proteomic characterization of kidney cancer, Molecular and Cellular Proteomics, May;8(5):971-85, 2009

Liu , J.-Y. Park, S.-H., Morisseau , C., Hwang , S. H., Hammock, B., Weiss, R.H., Sorafenib Has sEH Inhibitory Activity Which Contributes to Its Effect Profile in vivo, Molecular Cancer Therapeutics, 2009 Aug;8(8):2193-203, 2009

Taylor, S.L., Ganti, S., Bukanov N.O., Chapman, A., Fiehn, O., Osier, M., Kim, K., Weiss, R.H. A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease, American Journal of Physiology: Renal Physiology, in press, 2010

Weiss, R.H. p21Waf1/Cip1 as a therapeutic target in breast and other cancers, Cancer Cell, 4: 426-429, 2003